Related Experiment Video
Updated: Oct 4, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
708
A dual therapeutic system based on corrole-siRNA conjugates
Ifrodet Giorgees1, Fan Wu2, Zhen Shen2
1University of Ontario Institute of Technology, Faculty of Science, 2000 Simcoe Street North, Oshawa, ON L1G 0C5, Canada. Jean-Paul.Desaulniers@ontariotechu.ca.
Organic & Biomolecular Chemistry
|February 11, 2022
Summary
Researchers developed novel corrole-siRNA conjugates, combining gene silencing with photodynamic therapy (PDT) for potent, non-invasive treatments. These dual-action therapies show promise for advanced medical applications.
Area of Science:
- Medicinal Chemistry
- Biotechnology
- Nanomedicine
Background:
- Corrole molecules are versatile photosensitizers (PS) enabling tunable, non-invasive medical treatments.
- Current therapies often lack combined gene silencing and photodynamic effects.
Purpose of the Study:
- To develop novel corrole-functionalized short interfering RNAs (corrole-siRNAs).
- To evaluate the dual therapeutic potential of corrole-siRNAs for gene silencing and photodynamic therapy (PDT).
Main Methods:
- Synthesized novel corrole-phosphoramidites and a library of corrole-siRNAs.
- Assessed gene silencing efficacy using firefly luciferase reporter assays.
- Evaluated photodynamic therapy effects on cell viability.
Main Results:
- Corrole-siRNAs demonstrated dose-dependent gene knockdown in vitro.
- Potent gene silencing was observed, with IC50 values in picomolar range.
- Photodynamic therapy with corrole-siRNAs reduced cell viability by approximately 50% upon red light irradiation.
Conclusions:
- Corrole-siRNA conjugates offer a promising dual therapy approach.
- This combination integrates effective gene silencing with photodynamic cell death.
- Corrole-siRNAs represent a novel strategy for advanced therapeutic development.
Related Concept Videos
02:15Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
02:47Ribozymes
2.8K
2.8K
02:30siRNA - Small Interfering RNAs
17.1K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.1K
00:59Gene Therapy
26.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.0K
01:23RNA Interference
26.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.6K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K